Enteris BioPharma Inc.

Quick facts

Marketed products

• Leuprolide Depot · Oncology; Urology; Gynecology
  Leuprolide is a gonadotropin-releasing hormone (GnRH) agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to decreased testosterone and estrogen production.

Phase 2 pipeline

• Leuprolide Oral Tablet 10-mg BID
• Leuprolide Oral Tablet 4-mg BID
• Leuprolide Oral Tablet 4-mg QD

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Enteris BioPharma Inc. portfolio CI brief
• Enteris BioPharma Inc. pipeline updates RSS